Somatic PTEN mutation is detected in ~16% of endometrial atypical hyperplasia lesions, the precursors of endometrial cancers; however, most endometrial hyperplasia lesions are indolent and infrequently progress to endometrioid carcinoma, unless other molecular genetic events are acquired12,15. This evidence concerns the gene PTEN and endometrial cancer.